$6.47
0.00% day before yesterday
Nasdaq, Jun 12, 03:30 pm CET
ISIN
AGP8696W1045
Symbol
SVA
Sector
Industry

Sinovac Biotech Ltd. Stock price

$6.47
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+0.00 0.00% 5Y
+0.66 11.36% 10Y
+4.71 267.61% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
+0.00 0.00%
ISIN
AGP8696W1045
Symbol
SVA
Sector
Industry

Key metrics

Market capitalization $639.90m
Enterprise Value $-9.62b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 23.78
EV/Sales (TTM) EV/Sales -22.43
P/S ratio (TTM) P/S ratio 1.49
P/B ratio (TTM) P/B ratio 0.07
Revenue growth (TTM) Revenue growth 2.19%
Revenue (TTM) Revenue $429.20m
EBIT (operating result TTM) EBIT $-362.01m
Free Cash Flow (TTM) Free Cash Flow $-404.72m
Cash position $10.57b
EPS (TTM) EPS $-1.31
Short interest 0.26%
Show more

Is Sinovac Biotech Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Sinovac Biotech Ltd. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Sinovac Biotech Ltd.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Sinovac Biotech Ltd.:

Buy
100%

Financial data from Sinovac Biotech Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
429 429
2% 2%
100%
- Direct Costs 34 34
95% 95%
8%
395 395
300% 300%
92%
- Selling and Administrative Expenses 443 443
51% 51%
103%
- Research and Development Expense 337 337
17% 17%
79%
-232 -232
83% 83%
-54%
- Depreciation and Amortization 130 130
20% 20%
30%
EBIT (Operating Income) EBIT -362 -362
76% 76%
-84%
Net Profit -131 -131
64% 64%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Sinovac Biotech Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sinovac Biotech Ltd. Stock News

Neutral
Business Wire
about 12 hours ago
HONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of approximately 8% of the Company's outstanding shares, today issued the following letter in response to the Company's recent false and misleading claims relating to the upcoming Spec...
Neutral
Business Wire
one day ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it intends to file its definitive proxy materials in the coming days with the Securities and Exchange Commission (SEC) for the Special Meeting of Shareholders to be held on Wednesday, July 9, 2025 at 8:00 a.m. China Standard T...
Neutral
Business Wire
3 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and an approximately 8% shareholder in Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today sent a letter to shareholders. *** Dear Fellow Sinovac Shareholders, We, Vivo Capital (“Vivo”), write to you as fellow shareholders of S...
More Sinovac Biotech Ltd. News

Company Profile

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Head office Antigua and Barbuda
CEO Wei Yin
Founded 1993
Website www.sinovac.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today